منتجاتنا

Composition : Salflu® 125 HFA : Each actuation delivers Salmeterol (as Xinafoate) 25 mcg & Fluticasone Propionate BP 125 mcg.

Salflu® 250 HFA : Each actuation delivers Salmeterol (as Xinafoate) 25 mcg & Fluticasone Propionate BP 250 mcg.

Indications : Patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short acting beta-2-agonist or, Patients already adequately controlled on both inhaled corticosteroid and long-acting beta-2-agonist.

Dosage & Administration : Adults and adolescents 12 years and older: Two inhalations of Salflu® 125 HFA twice daily, or Two inhalations of Salflu® 250 HFA twice daily.